Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 202379

Expand all

ZYTIGA (ABIRATERONE ACETATE)
250MG Marketing Status: Prescription

Active Ingredient: ABIRATERONE ACETATE
Proprietary Name: ZYTIGA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 250MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N202379
Product Number: 001
Approval Date: Apr 28, 2011
Applicant Holder Full Name: JANSSEN BIOTECH INC
Marketing Status:  Prescription
Patent and Exclusivity Information

ZYTIGA (ABIRATERONE ACETATE)
500MG Marketing Status: Prescription

Active Ingredient: ABIRATERONE ACETATE
Proprietary Name: ZYTIGA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 500MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N202379
Product Number: 002
Approval Date: Apr 14, 2017
Applicant Holder Full Name: JANSSEN BIOTECH INC
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English